MedPath

NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN

Neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution USP (Sterile)

Approved
Approval ID

e2d2199c-3b8a-4071-9c01-d1e8879f9bff

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 9, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

neomycin sulfate, polymyxin b sulfate and gramicidin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6253
Application NumberANDA064047
Product Classification
M
Marketing Category
C73584
G
Generic Name
neomycin sulfate, polymyxin b sulfate and gramicidin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 4, 2011
FDA Product Classification

INGREDIENTS (8)

NEOMYCIN SULFATEActive
Quantity: 1.75 mg in 1 mL
Code: 057Y626693
Classification: ACTIB
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIB
GRAMICIDINActive
Quantity: 0.025 mg in 1 mL
Code: 5IE62321P4
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN - FDA Drug Approval Details